Liquid chromatography-mass spectrometric analysis of lipids present in human meibomian gland secretions

被引:79
作者
Butovich, Igor A. [1 ]
Uchiyama, Eduardo [1 ]
Di Pascuale, Mario A. [1 ]
McCulley, James P. [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Ophthalmol, Dallas, TX 75390 USA
关键词
lipids; HPLC; mass spectrometry; tear film lipid layer; human Meibomian gland;
D O I
10.1007/s11745-007-3080-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of the study was to qualitatively characterize the major lipid species present in human meibomian gland secretions (MGS) by means of high-performance liquid chromatography with atmospheric pressure ionization mass spectrometric detection of the analytes (NP HPLC-MS). Two different NP HPLC-MS methods have been developed to analyze lipid species that were expected to be present in MGS. The first method was optimized for the analysis of relatively nonpolar lipids [wax esters (WE), di- and triacyl glycerols (DAG and TAG), cholesterol (Chl) and its esters (Chl-E), and ceramides (Cer)], while the second method was designed to separate and detect phospholipids. The major lipid species in MGS were found to be WE, Chl-E, and TAG. A minor amount of free Chl (less then 0.5% of the Chl-E fraction) was detected in MGS. No appreciable amounts of DAG and Cer were found in MGS. The second NP HPLC-MS method, capable of analyzing model mixtures of authentic phospholipids (e.g. phosphatidylglycerol, phosphatidylethanolamine, phosphatidic acid, phosphatidylinositol, phosphatidylserine, phosphatidylcholine, and sphingomyelin) in submicrogram/mL concentrations, showed little or no presence of these species in the MGS samples. These observations suggest that MGS are a major source of the nonpolar lipids of the WE and Chl-E families for the tear film lipid layer (TFLL), but not of the previously reported phospholipid components of the TFLL.
引用
收藏
页码:765 / 776
页数:12
相关论文
共 40 条
[12]  
King-Smith PE, 2000, INVEST OPHTH VIS SCI, V41, P3348
[13]   Effect of androgen deficiency on the human meibomian gland and ocular surface [J].
Krenzer, KL ;
Dana, MR ;
Ullman, MD ;
Cermak, JM ;
Tolls, DB ;
Evans, JE ;
Sullivan, DA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) :4874-4882
[14]   Correlation of the Schirmer 1 and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease [J].
Macri, A ;
Pflugfelder, S .
ARCHIVES OF OPHTHALMOLOGY, 2000, 118 (12) :1632-1638
[15]   Evaporation from the ocular surface [J].
Mathers, W .
EXPERIMENTAL EYE RESEARCH, 2004, 78 (03) :389-394
[16]  
MATHERS WD, 1993, OPHTHALMOLOGY, V100, P347
[17]   MEIBOMIAN GLAND MORPHOLOGY AND TEAR OSMOLARITY - CHANGES WITH ACCUTANE THERAPY [J].
MATHERS, WD ;
SHIELDS, WJ ;
SACHDEV, MS ;
PETROLL, WM ;
JESTER, JV .
CORNEA, 1991, 10 (04) :286-290
[18]  
McCulley J P, 1997, Trans Am Ophthalmol Soc, V95, P79
[19]   MEIBOMIAN KERATOCONJUNCTIVITIS [J].
MCCULLEY, JP ;
SCIALLIS, GF .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1977, 84 (06) :788-793
[20]  
MCCULLEY JP, 1998, CONTACTOLOGIA, V20, P45